Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest ARMISTICE CAPITAL, LLC Stock Portfolio

$7.95Billion– No. of Holdings #250

ARMISTICE CAPITAL, LLC Performance:
2024 Q2: -13.52%YTD: -9.97%2023: -1.65%

Performance for 2024 Q2 is -13.52%, and YTD is -9.97%, and 2023 is -1.65%.

About ARMISTICE CAPITAL, LLC and 13F Hedge Fund Stock Holdings

ARMISTICE CAPITAL, LLC is a hedge fund based in NEW YORK, NY. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $5.6 Billions. In it's latest 13F Holdings report, ARMISTICE CAPITAL, LLC reported an equity portfolio of $7.9 Billions as of 30 Jun, 2024.

The top stock holdings of ARMISTICE CAPITAL, LLC are PTCT, SUPN, NBIX. The fund has invested 2.7% of it's portfolio in PTC THERAPEUTICS INC and 1.8% of portfolio in SUPERNUS PHARMACEUTICALS INC.

The fund managers got completely rid off DECIPHERA PHARMACEUTICALS IN (DCPH), POST HLDGS INC (POST) and NOMAD FOODS LTD stocks. They significantly reduced their stock positions in M & T BK CORP (MTB), ON HLDG AG and CEA INDUSTRIES INC (CEAD). ARMISTICE CAPITAL, LLC opened new stock positions in SIMPLY GOOD FOODS CO (SMPL), SCILEX HOLDING CO and BRISTOL-MYERS SQUIBB CO (BMY). The fund showed a lot of confidence in some stocks as they added substantially to BLOOMIN BRANDS INC (BLMN), BIOXCEL THERAPEUTICS INC (BTAI) and ERMENEGILDO ZEGNA N V (ZGN).
ARMISTICE CAPITAL, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024

ARMISTICE CAPITAL, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that ARMISTICE CAPITAL, LLC made a return of -13.52% in the last quarter. In trailing 12 months, it's portfolio return was -10.61%.

New Buys

Ticker$ Bought
simply good foods co34,582,300
scilex holding co23,063,500
bristol-myers squibb co20,385,700
rigel pharmaceuticals inc13,349,300
dominos pizza inc12,784,800
coty inc8,882,970
t2 biosystems inc8,853,720
cerevel therapeutics hldng i8,249,270

New stocks bought by ARMISTICE CAPITAL, LLC

Additions

Ticker% Inc.
bloomin brands inc1,679
bioxcel therapeutics inc705
ermenegildo zegna n v547
immunocore hldgs plc495
cava group inc422
entero therapeutics inc366
inari med inc353
alkermes plc301

Additions to existing portfolio by ARMISTICE CAPITAL, LLC

Reductions

Ticker% Reduced
m & t bk corp-95.79
on hldg ag-91.98
cea industries inc-91.67
coca cola co-77.25
abercrombie & fitch co-73.18
goodyear tire & rubr co-68.52
brookfield corp-66.78
aspira womens health inc-59.55

ARMISTICE CAPITAL, LLC reduced stake in above stock

Sold off

Ticker$ Sold
steakholder foods ltd-4,318,150
erasca inc-12,714,300
deciphera pharmaceuticals in-92,807,000
terran orbital corporation-4,716,000
coeptis therapeutics hldgs i-901,202
trevena inc-709,145
rigel pharmaceuticals inc-22,732,800
nomad foods ltd-26,435,500

ARMISTICE CAPITAL, LLC got rid off the above stocks

Sector Distribution

ARMISTICE CAPITAL, LLC has about 56.6% of it's holdings in Healthcare sector.

Sector%
Healthcare56.6
Others15.3
Consumer Cyclical10
Consumer Defensive8.8
Technology7.2

Market Cap. Distribution

ARMISTICE CAPITAL, LLC has about 29.7% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MID-CAP32.2
LARGE-CAP25.6
UNALLOCATED16.7
SMALL-CAP16.6
MEGA-CAP4.1
MICRO-CAP2.8
NANO-CAP1.9

Stocks belong to which Index?

About 61.9% of the stocks held by ARMISTICE CAPITAL, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200040.5
Others38.1
S&P 50021.4
Top 5 Winners (%)%
RIGL
rigel pharmaceuticals inc
754.2 %
NXL
nexalin technology inc
713.4 %
STAF
staffing 360 solutions inc
555.7 %
ONFO
onfolio holdings inc
512.8 %
SNGX
soligenix inc
507.1 %
Top 5 Winners ($)$
AGIO
agios pharmaceuticals inc
32.8 M
RIGL
rigel pharmaceuticals inc
11.8 M
PTCT
ptc therapeutics inc
9.7 M
DYN
dyne therapeutics inc
6.7 M
INCY
incyte corp
6.1 M
Top 5 Losers (%)%
CMG
chipotle mexican grill inc
-98.0 %
BCTX
briacell therapeutics corp
-80.2 %
ALGS
aligos therapeutics inc
-63.8 %
BIAF
bioaffinity technologies inc
-60.7 %
APVO
aptevo therapeutics inc
-60.0 %
Top 5 Losers ($)$
CMG
chipotle mexican grill inc
-385.9 M
SUPN
supernus pharmaceuticals inc
-30.2 M
CYTK
cytokinetics inc
-27.7 M
MGNX
macrogenics inc
-26.2 M
EXAS
exact sciences corp
-26.1 M

ARMISTICE CAPITAL, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL, LLC has 250 stocks in it's portfolio. About 14.1% of the portfolio is in top 10 stocks. CMG proved to be the most loss making stock for the portfolio. AGIO was the most profitable stock for ARMISTICE CAPITAL, LLC last quarter.

Last Reported on: 14 Aug, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions